Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 13cyclopia sequence 7Neoplasms 5Polycystic Ovary Syndrome 4Prostatic Neoplasms 3Multiple Myeloma 3Lung Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Vomiting 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Obesity 2Neoplasms, Plasma Cell 2Nausea 2Hematologic Diseases 2Fatigue 2Depression 2Weight Loss 1Warts 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Sleepiness 1Sezary Syndrome 1Prostatic Intraepithelial Neoplasia 1Primary Myelofibrosis 1Peripheral Nervous System Diseases 1Pediatric Crohn's disease 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1

Interventions

Surveys and Questionnaires 1Sugars 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Hyperinsulinism × Sugars × Clear all
NCT01697566 2025-06-11

An Endometrial Cancer Chemoprevention Study of Metformin

M.D. Anderson Cancer Center

Phase 3 Completed
29 enrolled 12 charts
Other

Hyperinsulinism, Motor Activity, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡